Altınöz, M. Et Al. 2016. Combined presence of three MGMT gene-polymorphisms in a glioblastoma patient, who developed severe myelosuppression following temozolomide chemotherapy. 12th Meeting of the European Association of Neuro-Oncology , 40.

Altınöz, M., Ozek, E., Ekmekçi, C. G., YENMİŞ, G., & ELMACI, İ., (2016). Combined presence of three MGMT gene-polymorphisms in a glioblastoma patient, who developed severe myelosuppression following temozolomide chemotherapy . 12th Meeting of the European Association of Neuro-Oncology (pp.40).

Altınöz, Meriç Et Al. "Combined presence of three MGMT gene-polymorphisms in a glioblastoma patient, who developed severe myelosuppression following temozolomide chemotherapy," 12th Meeting of the European Association of Neuro-Oncology, 2016

Altınöz, Meriç Et Al. "Combined presence of three MGMT gene-polymorphisms in a glioblastoma patient, who developed severe myelosuppression following temozolomide chemotherapy." 12th Meeting of the European Association of Neuro-Oncology , pp.40, 2016

Altınöz, M. Et Al. (2016) . "Combined presence of three MGMT gene-polymorphisms in a glioblastoma patient, who developed severe myelosuppression following temozolomide chemotherapy." 12th Meeting of the European Association of Neuro-Oncology , p.40.

@conferencepaper{conferencepaper, author={Meriç Altınöz Et Al. }, title={Combined presence of three MGMT gene-polymorphisms in a glioblastoma patient, who developed severe myelosuppression following temozolomide chemotherapy}, congress name={12th Meeting of the European Association of Neuro-Oncology}, city={}, country={}, year={2016}, pages={40} }